Prof K Prise, Dr Aidan Cole
No more applications being accepted
Funded PhD Project (European/UK Students Only)
About the Project
The successful applicant will join an experienced and dynamic team of Prostate Cancer Oncologists and Clinical Radiobiologists to investigate the biological basis underpinning radionuclide therapies in advanced prostate cancer. Targeted radionuclide therapy is a rapidly evolving field with clinical applications likely to be standard of care in many solid organ malignancies over the next decade. Queen’s University and the Northern Ireland Cancer Centre has considerable experience in delivery of radionuclides (radium-223) to patients with metastatic prostate cancer. These treatments can improve overall survival and symptoms for patients with advanced disease.
We aim to investigate a range of in vitro and in vivo pre-clinical models to better determine mechanism of action and to guide combination therapies (chemotherapy, hormonal therapy, radiotherapy, bisphosphonates and novel agents) for patients with prostate cancer. The appointed student will receive comprehensive training in pre-clinical laboratory techniques to enable completion of the project and will work closely with the oncology team to best design clinically relevant research models.
ENTRY REQUIREMENTS
Candidates should have or expect to obtain a 2:1 or higher Honours degree or equivalent in a relevant biomedical or life sciences subject.
English Language
Candidates applying from countries where the first language is not English should produce evidence of their competence through a qualification such as IELTS or TOEFL score.
The minimum recommended score for the School of Medicine, Dentistry and Biomedical Science is:
• IELTS score of 6.0 with not less than 5.5 in each of the four component elements of listening, reading, speaking and writing taken within the last 2 years;
• TOEFL score of 80+ (internet basted test), taken within the last 2 years, with minimum component scores of; Listening 17, Reading 18, Speaking 20, Writing 17);
• A valid Certificate of Proficiency in English grade A or B;
• A valid Certificate of Advanced English grade A; or
• A first or upper second class honours degree from a university based in the UK, Republic of Ireland or other suitably quality assured location in a country deemed by the UK Border Agency to be majority English speaking.
For a list of English Language qualifications also accepted by the School and University please see the following link:
http://www.qub.ac.uk/International/International-students/Applying/English-language-requirements/#English
The English Language Unit (ELU) offers both pre-sessional and in-sessional courses in English for academic purposes and study skills. Courses vary in length and full information can be obtained from the ELU http://www.qub.ac.uk/tefl/
Funding Notes
*FUNDING CONFIRMED – Department for the Economy (DfE) Award*
Eligibility for both fees (£4,195 for 2017/18) and maintenance (£14,553 for 2017/18) depends on the applicants being either an ordinary UK resident or those EU residents who have lived permanently in the UK for the 3 years immediately preceding the start of the studentship.
Non UK residents who hold EU residency may also apply but if successful may receive fees only.
For further details re eligibility criteria (including academic, citizenship and residency criteria) please click on the following link: http://www.delni.gov.uk/index/further-and-higher-education/higher-education/studentfinance/he-student-info-postgrad-finance.htm
References
Please visit the School of Medicine, Dentistry and Biomedical Sciences, Centre for Cancer Research and Cell Biology, website for further details about the Centre:
http://www.qub.ac.uk/research-centres/CentreforCancerResearchCellBiology/
When applying, please choose 'MEDICINE' as your subject area/School.
Continue with Facebook
